Xuejiao Qi

Xuejiao Qi

Auto-generated profile, based on publicly available information

Xuejiao Qi

The Second Hospital of Hebei Medical University, Shijiazhuang, PR China. 1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
JJJie Jin
Jie Jin
YCYumeng Cui
Yumeng Cui
HNHuicong Niu
Huicong Niu
YLYanli Lin
Yanli Lin
XWXiaojie Wu
Xiaojie Wu
HBHui Bu
Hui Bu
Leptomeningeal metastasis (LM) is a devastating complication of advanced non–small cell lung cancer (NSCLC). Its diagnosis and monitoring can be challenging. Recently, extracellular vesicle (EV) miRNAs have become a new noninvasive diagnostic biomarker. The purpose of this study was to examine the clinical value and role of EV miRNAs in NSCLC-LM. Next-generation sequencing analysis revealed that miRNAs with differential expression of EVs in sera of patients with NSCLC with LM and non-LM were detected to identify biological markers for the diagnosis of LM. Cellular and in vivo experiments were conducted to explore the pathogenesis of EV miRNA promoting LM in NSCLC. In the present study, we first demonstrated that the serum level of EV-associated miR-374a-5p in patients with LM of lung cancer was much higher than that in patients without LM and was correlated with the survival time of patients with LM. Further studies showed that EV miR-374a-5p efficiently destroys tight junctions and the integrity of the cerebral microvascular endothelial cell barrier, resulting in increased blood–brain barrier permeability. Mechanistically, miR-374a-5p regulates the distribution of ZO1 and occludin in endothelial cells by targeting γ-adducin, increasing vascular permeability and promoting LM. Implications: These results suggest that serum NSCLC–derived EV miR-374a-5p is involved in premetastatic niche formation by regulating the permeability of the blood–brain barrier to promote NSCLC-LM and can be used as a blood biomarker for the diagnosis and prognosis of NSCLC-LM.



2 August 2024
Verified
Other
Open access
JJJie Jin
Jie Jin
YCYumeng Cui
Yumeng Cui
HNHuicong Niu
Huicong Niu
YLYanli Lin
Yanli Lin
XWXiaojie Wu
Xiaojie Wu
HBHui Bu
Hui Bu
Leptomeningeal metastasis (LM) is a devastating complication of advanced non–small cell lung cancer (NSCLC). Its diagnosis and monitoring can be challenging. Recently, extracellular vesicle (EV) miRNAs have become a new noninvasive diagnostic biomarker. The purpose of this study was to examine the clinical value and role of EV miRNAs in NSCLC-LM. Next-generation sequencing analysis revealed that miRNAs with differential expression of EVs in sera of patients with NSCLC with LM and non-LM were detected to identify biological markers for the diagnosis of LM. Cellular and in vivo experiments were conducted to explore the pathogenesis of EV miRNA promoting LM in NSCLC. In the present study, we first demonstrated that the serum level of EV-associated miR-374a-5p in patients with LM of lung cancer was much higher than that in patients without LM and was correlated with the survival time of patients with LM. Further studies showed that EV miR-374a-5p efficiently destroys tight junctions and the integrity of the cerebral microvascular endothelial cell barrier, resulting in increased blood–brain barrier permeability. Mechanistically, miR-374a-5p regulates the distribution of ZO1 and occludin in endothelial cells by targeting γ-adducin, increasing vascular permeability and promoting LM.Implications: These results suggest that serum NSCLC–derived EV miR-374a-5p is involved in premetastatic niche formation by regulating the permeability of the blood–brain barrier to promote NSCLC-LM and can be used as a blood biomarker for the diagnosis and prognosis of NSCLC-LM.

2 August 2024
Verified
Other
Open access
JJJie Jin
Jie Jin
YCYumeng Cui
Yumeng Cui
HNHuicong Niu
Huicong Niu
YLYanli Lin
Yanli Lin
XWXiaojie Wu
Xiaojie Wu
HBHui Bu
Hui Bu
MiR-374a-5p reduces cell-cell junctions and does not reduce the amount of tight junction protein.

2 August 2024
Verified
Other
Open access
PDF file
JJJie Jin
Jie Jin
YCYumeng Cui
Yumeng Cui
HNHuicong Niu
Huicong Niu
YLYanli Lin
Yanli Lin
XWXiaojie Wu
Xiaojie Wu
HBHui Bu
Hui Bu
EVs miR-374a-5p down-regulates ADD3 and reduces cell-cell junctions.